Recently Pharmazz India Pvt Ltd presented its nine years of research done for developing life saving drugs at a conference. These drugs will be helpful in cases of accidents, maternal mortality, diarrhoea and burns as these can control excessive blood loss or fluid loss from the patient’s body to such an extent that doctors can effectively get extra time of 6-7 hours to save the life. The event was attended by medical researchers from India and the US.

Twenty highly-credentialed Indians are executing human trial tests in 25 major Indian medical institutions, that address shock from serious blood loss, stroke from reduced blood supply to the brain, Alzheimer’s disease and injuries to the spinal cord.

“This conference shows Indian doctors and scientists collaborating on new technological answers to life-threatening challenges faced by millions of Indians,” Pharmazz Co-founder Anil Gulati, PhD, MD, said.

Millions of Indians are afflicted by these injuries and diseases every year. For instance, we have very high rates of car crashes. People are injured and bleed. Millions have lost their lives from the blood loss. Our drug has already saved lives in clinical trials, and we hope it will be successful and save more,” Dr Gulati said.

Considering the preclinical and clinical data till date, the chances of survival are very high. The drug has shown remarkable effects in patients of hypovolemic shock. Three important surrogate clinical endpoints for hypovolemic shock are blood pressure, blood lactate and base-deficit. The results demonstrate all three points significantly (P<0.001) improved.